Reddys, Apotex, Sun Pharmaceuticals, among others
Medication is billed quarterly at ~$837 per 3-month supply for brand-name GLP-1s, the payment shock our audience flags most often
Mitigation strategies include frequent glucose monitoring when changes are made to insulin dosage, oral hypoglycemic medications, meal patterns, physical activity, and in cases of renal or hepatic impairment or hypoglycemia unawareness, with consideration for dose reduction
Prior to the current patent-expiry competition, a single semaglutide pen in Brazil cost approximately R$230 (approximately $45 USD) for earlier lower-dose presentations roughly 14% of a minimum-wage worker's monthly income for a single month's treatment dose
Supply planning for a complete retatrutide protocol Running out of peptide mid-escalation is not just inconvenient